Prognostic value of brain natriuretic peptide in acute heart failure: mortality and hospital readmission. 2008

Julio Núñez, and Eduardo Núñez, and Rocío Robles, and Vicent Bodí, and Juan Sanchis, and Arturo Carratalá, and Manuel Aparici, and Angel Llàcer
Servicio de Cardiología, Hospital Clínic i Universitari, Universidad de Valencia, Valencia, Spapin. yulnunez@gmail.com

The prognostic value of brain natriuretic peptide (BNP) measurement in patients with acute heart failure is not well understood. The aim of this study was to investigate the relationship between the BNP level and mortality and readmission for acute heart failure. We studied 569 consecutive patients who were admitted with a diagnosis of acute heart failure. The BNP level was measured after the patient became clinically stable. The relationship between the BNP level and mortality was assessed by Cox regression analysis, and the relationship with readmission, by competing risks regression analysis. During a median follow-up period of 9 (range, 3-18) months, 156 deaths (27.4%) and 140 readmissions (24.6%) occurred. Multivariate analysis demonstrated a positive linear association between the risk of death and the BNP quintile. In contrast, the BNP level did not predict readmission for acute heart failure, mainly because of the effect of death as a competing outcome.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010359 Patient Readmission Subsequent admissions of a patient to a hospital or other health care institution for treatment. Hospital Readmission,Rehospitalization,Unplanned Hospital Readmissions,Unplanned Readmission,30 Day Readmission,Hospital Readmissions,Readmission, Hospital,Readmissions, Hospital,Thirty Day Readmission,30 Day Readmissions,Hospital Readmission, Unplanned,Hospital Readmissions, Unplanned,Readmission, Patient,Readmission, Thirty Day,Readmission, Unplanned,Rehospitalizations,Thirty Day Readmissions,Unplanned Hospital Readmission,Unplanned Readmissions
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D020097 Natriuretic Peptide, Brain A PEPTIDE that is secreted by the BRAIN and the HEART ATRIA, stored mainly in cardiac ventricular MYOCARDIUM. It can cause NATRIURESIS; DIURESIS; VASODILATION; and inhibits secretion of RENIN and ALDOSTERONE. It improves heart function. It contains 32 AMINO ACIDS. Brain Natriuretic Peptide,Nesiritide,B-Type Natriuretic Peptide,BNP Gene Product,BNP-32,Brain Natriuretic Peptide-32,Natrecor,Natriuretic Factor-32,Natriuretic Peptide Type-B,Type-B Natriuretic Peptide,Ventricular Natriuretic Peptide, B-type,BNP 32,Brain Natriuretic Peptide 32,Natriuretic Factor 32,Natriuretic Peptide Type B,Natriuretic Peptide, B-Type,Natriuretic Peptide, Type-B,Natriuretic Peptide-32, Brain,Peptide, Brain Natriuretic,Peptide-32, Brain Natriuretic,Type B Natriuretic Peptide,Ventricular Natriuretic Peptide, B type

Related Publications

Julio Núñez, and Eduardo Núñez, and Rocío Robles, and Vicent Bodí, and Juan Sanchis, and Arturo Carratalá, and Manuel Aparici, and Angel Llàcer
October 2003, Medizinische Klinik (Munich, Germany : 1983),
Julio Núñez, and Eduardo Núñez, and Rocío Robles, and Vicent Bodí, and Juan Sanchis, and Arturo Carratalá, and Manuel Aparici, and Angel Llàcer
January 2002, Revista espanola de cardiologia,
Julio Núñez, and Eduardo Núñez, and Rocío Robles, and Vicent Bodí, and Juan Sanchis, and Arturo Carratalá, and Manuel Aparici, and Angel Llàcer
February 2009, Journal of cardiac failure,
Julio Núñez, and Eduardo Núñez, and Rocío Robles, and Vicent Bodí, and Juan Sanchis, and Arturo Carratalá, and Manuel Aparici, and Angel Llàcer
April 2023, Circulation journal : official journal of the Japanese Circulation Society,
Julio Núñez, and Eduardo Núñez, and Rocío Robles, and Vicent Bodí, and Juan Sanchis, and Arturo Carratalá, and Manuel Aparici, and Angel Llàcer
December 2010, International journal of cardiology,
Julio Núñez, and Eduardo Núñez, and Rocío Robles, and Vicent Bodí, and Juan Sanchis, and Arturo Carratalá, and Manuel Aparici, and Angel Llàcer
March 2007, Clinical chemistry,
Julio Núñez, and Eduardo Núñez, and Rocío Robles, and Vicent Bodí, and Juan Sanchis, and Arturo Carratalá, and Manuel Aparici, and Angel Llàcer
October 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Julio Núñez, and Eduardo Núñez, and Rocío Robles, and Vicent Bodí, and Juan Sanchis, and Arturo Carratalá, and Manuel Aparici, and Angel Llàcer
September 2020, Heart, lung & circulation,
Julio Núñez, and Eduardo Núñez, and Rocío Robles, and Vicent Bodí, and Juan Sanchis, and Arturo Carratalá, and Manuel Aparici, and Angel Llàcer
September 2021, JACC. Heart failure,
Julio Núñez, and Eduardo Núñez, and Rocío Robles, and Vicent Bodí, and Juan Sanchis, and Arturo Carratalá, and Manuel Aparici, and Angel Llàcer
January 2008, Critical care (London, England),
Copied contents to your clipboard!